Literature DB >> 6976857

Urinary p-aminobenzoic acid determined in the pancreatic function test by liquid chromatography, with electrochemical detection.

S Ito, K Maruta, Y Imai, T Kato, M Ito, S Nakajima, K Fujita, T Kurahashi.   

Abstract

We describe a liquid-chromatographic procedure for determining urinary p-aminobenzoic acid (PABA) in the exocrine pancreatic function test. The urine specimen, collected for 6 h after oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid, is hydrolyzed in 4 mol/L NaOH containing m-hydroxybenzoic acid as internal standard, to free PABA metabolites, then diluted and injected into the chromatograph. PABA and the internal standard are eluted from a reversed-phase C18 column with phosphate buffer (0.2 mol/L, pH 3.5)/acetonitrile, 87.5/12.5 (by vol), and detected with an electrochemical detector at +1100 mV. Urinary PABA concentration as measured by this method agreed well with that by colorimetry involving p-dimethylaminocinnamaldehyde. The present procedure is specific for PABA, precise, and fairly rapid. We hope that the present method will minimize instances of interference from drugs, which cannot be avoided in the colorimetric method.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6976857

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Improved specificity of the PABA test with p-aminosalicylic acid (PAS).

Authors:  F J Hoek; F A van den Bergh; J T Klein Elhorst; J L Meijer; E Timmer; G N Tytgat
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

2.  Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.

Authors:  V S Hubbard; R O Wolf; L A Lester; A C Egge
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.